ONdrugDelivery Magazine, with over 40,000 readers, is a well-respected drug delivery publication featuring insights and articles from global industry experts at top drug delivery companies.
As new-generation biologics become more concentrated and thicker, drug delivery device developers have to rethink earlier designs to handle these new formulations.
If these medications could be given by injection under the skin, it would help ease some strain on healthcare systems, as this method is easier for people to use at home compared to intravenous drug delivery.
But to make sure medications can be given effectively outside a clinical setting, it’s essential for manufacturers to develop drug delivery solutions that address the needs of patients and caregivers, as well as healthcare professionals.
In this article, George I’ons explores the advantages of delivering new drugs under the skin and the key considerations device makers need to keep in mind when designing delivery systems.